Related Experiment Video
Updated: Dec 25, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[The treatment of diabetes mellitus: myths and evidence]
1Universitätsklinikum Hamburg-Eppendorf, Haus O 35, Martinistraße 52, 20246, Hamburg, Deutschland. goeke@uke.de.
Abstract:
For more than 3500 years, metabolic disorders were recognized by symptoms similar to those indicating diabetes mellitus today. Over centuries, explanations remained elusive and shed sparse light on the origin of the disease and any treatments. The poor prognosis triggered myths and misconceptions, some even lasting until today. Two hundred years ago, major advances were made in the understanding of the pathophysiology, which has led to more successful treatments. Presently, useful preventive, diagnostic, and therapeutic procedures exist. However, old myths and misconceptions still influence the treatments. This article reviews ongoing myths dealing with the genesis and treatment of diabetes and the growing evidence for improved therapies.Increasingly more studies focus on cardiovascular endpoints while considering more realistic therapeutic goals. This paves the way to polyvalent treatment concepts reaching beyond the classic glucocentric treatment concept of type 2 diabetes. The introduction of molecular medicine, the current opportunities and future prospects of new drugs, personalized medicine, and technical innovations prompt hopes and expectations for a change of paradigms in therapeutic concepts. It is quite possible that traditional and newly generated myths will accompany this development. This has to be kept in mind when developing new concepts for treatment.
Insights
This review examines persistent myths about diabetes mellitus origins and treatment, highlighting advancements in understanding and therapy. It discusses evolving treatment strategies beyond glucose control, incorporating molecular medicine and personalized approaches.
Area of Science:
- Endocrinology and Metabolic Diseases
- History of Medicine
Background:
- Metabolic disorders with diabetes mellitus-like symptoms have been recognized for over 3500 years.
- Historical understanding of diabetes mellitus etiology and treatment was limited, fostering persistent myths.
- Significant advances in pathophysiology understanding occurred approximately 200 years ago, improving treatment efficacy.
Purpose of the Study:
- To review current myths surrounding the genesis and treatment of diabetes mellitus.
- To discuss the growing evidence for improved diabetes therapies.
- To explore the impact of molecular medicine and personalized approaches on future diabetes treatment paradigms.
Main Methods:
- Literature review of historical and current understanding of diabetes mellitus.
- Analysis of evolving therapeutic concepts, moving beyond glucocentric approaches.
- Discussion of the role of molecular medicine, new drugs, personalized medicine, and technical innovations.
Main Results:
- Despite advances, outdated myths continue to influence diabetes mellitus treatment.
- Current research increasingly focuses on cardiovascular endpoints and realistic therapeutic goals.
- Polyvalent treatment concepts are emerging, extending beyond traditional glucose-centered strategies.
Conclusions:
- New therapeutic paradigms for diabetes mellitus are emerging, driven by molecular medicine and personalized approaches.
- Traditional and novel myths may persist and influence the development of future diabetes treatments.
- Awareness of these myths is crucial for developing effective and evidence-based diabetes care strategies.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

